Digostics, a biotech developing the world's first at-home oral glucose tolerance test for diabetes, has raised £520,474 and counting from 108 investors on crowdfunding platform Crowdcube.

The FDA is amplifying an effort underway at medical device distributor Medline that aims to correct certain neurosurgery kits ...

AAA Biotech Launches Validated Antibodies & Research Reagents Browse AAA Biotech's new range of validated antibodies, ELISA kits, and cultu ...

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a ...

NextShark Ventures is proud to welcome Remission Biotech as the latest addition to its portfolio of companies redefining the ...

A phase 3 trial of Cogent Biosciences’ bezuclastinib has hit its primary endpoint, teeing the biotech up to seek FDA approval for a potential rival to Blueprint Medicines’ Ayvakit.

Mammalian HCP ELISA Kits represent a useful technology in biopharmaceutical quality control processes. They can detect and quantify residual host cell proteins that may contaminate biological products ...

It’s called the Amgen Biotech Experience and for a number of teachers across the Piedmont, it could be the key to helping ...

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs ...

Komfo Anokye Teaching Hospital (KATH) is one of the sites where the the global RECOVERY Trial is being conducted. Enrollment has increased following the introduction of rapid test kits that detect ...

Studies suggest that some commercially available health tests are inaccurate and unsuitable for public use. Rebecca Coombes , Hristio Boytchev , and Gareth Iacobucci ask if regulation is adequately ...

Key Points - Revenue rose 3.0 % year over year to $10.85 billion, surpassing analyst expectations.- Non-GAAP earnings per ...